SirolimusImmunosuppressive AgentsKidney TransplantationTacrolimusGraft RejectionCyclosporineGraft SurvivalTransplantsMycophenolic AcidTransplantation, HomologousHeart TransplantationTransplantationCalcineurinTissue DonorsTreatment OutcomeLung TransplantationTime FactorsImmunosuppressionLiving DonorsRetrospective StudiesPostoperative ComplicationsDrug SubstitutionBone Marrow TransplantationTissue and Organ ProcurementHematopoietic Stem Cell TransplantationLymphangioleiomyomatosisWaiting ListsDrug Therapy, CombinationKidneyAngiomyolipomaCreatinineGraft vs Host DiseaseFollow-Up StudiesTOR Serine-Threonine KinasesCadaverIslets of Langerhans TransplantationKidney Failure, ChronicLiver FailureFetal Tissue TransplantationCytomegalovirus InfectionsImmunocompromised HostAntilymphocyte SerumTransplantation ConditioningHistocompatibility TestingBiopsyGlomerular Filtration RateLymphangiomyomaDrug MonitoringTransplantation ImmunologyInjections, IntraocularProspective StudiesRisk FactorsCoronary RestenosisKidney DiseasesRecurrenceHeart-Lung TransplantationChyleRenal InsufficiencyLiver DiseasesOpportunistic InfectionsKidney Function TestsBrain Tissue TransplantationSurvival RateTransplantation, AutologousHematologic NeoplasmsLiver TransplantationFluorescence Polarization ImmunoassayPolyenesDrug-Eluting StentsBronchiolitis ObliteransInfectionSurvival AnalysisTransplantation, HeterotopicIncidenceKaplan-Meier EstimateHistocompatibilityCardiovascular AgentsTransplantation ToleranceCytomegalovirusAcute DiseaseThrombotic MicroangiopathiesStentsBK VirusAntibiotics, AntineoplasticAdrenal Cortex HormonesDrug ImplantsCold IschemiaDrug InteractionsHLA AntigensGanciclovirIsoantibodiesPolyomavirus InfectionsTubulin ModulatorsSteroidsOxaloacetic AcidFatal OutcomeCohort StudiesPolycystic Kidney, Autosomal DominantRisk AssessmentLymphoproliferative Disorders